Edwards Lifesciences Corporation Financing Cash Flow
Edwards Lifesciences Corporation (EW) reported Financing Cash Flow of -$451.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- Edwards Lifesciences Corporation net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$300.00K, a 100.57% decline year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$451.20M.
- Edwards Lifesciences Corporation net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$11.40M, a 139.86% decline year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$740.10M.
- Edwards Lifesciences Corporation net cash provided by (used in) financing activities for fiscal 2025 was -$956.80M.
- Edwards Lifesciences Corporation net cash provided by (used in) financing activities for fiscal 2024 was -$983.00M.
- Edwards Lifesciences Corporation net cash provided by (used in) financing activities for fiscal 2023 was -$711.00M.
- Edwards Lifesciences Corporation net cash provided by (used in) financing activities for fiscal 2022 was -$1.58B.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$451.50M 10-Q · filed 2026-08-04 | -$462.90M derived: sum of 3 quarters · filed 2026-08-04 | -$1.20B derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$451.20M 10-Q · filed 2026-05-06 | -$462.60M derived: sum of 2 quarters · filed 2026-05-06 | -$1.20B derived: sum of 3 quarters · filed 2026-05-06 | -$1.15B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$751.50M derived: sum of 2 quarters · filed 2026-02-25 | -$698.80M derived: sum of 3 quarters · filed 2026-08-04 | -$956.80M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$740.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$687.40M derived: sum of 2 quarters · filed 2026-08-04 | -$945.40M 10-Q · filed 2025-11-05 | -$916.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $52.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$205.30M 10-Q · filed 2026-08-04 | -$176.70M derived: sum of 3 quarters · filed 2026-08-04 | -$1.15B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$258.00M 10-Q · filed 2026-05-06 | -$229.40M derived: sum of 2 quarters · filed 2026-05-06 | -$1.21B derived: sum of 3 quarters · filed 2026-05-06 | -$1.30B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $28.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$948.10M derived: sum of 2 quarters · filed 2026-02-25 | -$1.04B derived: sum of 3 quarters · filed 2026-02-25 | -$983.00M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$976.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.07B derived: sum of 2 quarters · filed 2025-11-05 | -$1.01B 10-Q · filed 2025-11-05 | -$1.42B derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$96.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$34.90M 10-Q · filed 2025-08-06 | -$448.10M derived: sum of 3 quarters · filed 2026-02-25 | -$591.40M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $61.70M 10-Q · filed 2025-05-06 | -$351.50M derived: sum of 2 quarters · filed 2026-02-25 | -$494.80M derived: sum of 3 quarters · filed 2026-02-25 | -$442.70M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$413.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$556.50M derived: sum of 2 quarters · filed 2026-02-25 | -$504.40M derived: sum of 3 quarters · filed 2026-02-25 | -$711.00M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$143.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$91.20M derived: sum of 2 quarters · filed 2024-11-06 | -$297.80M 10-Q · filed 2024-11-06 | -$1.14B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $52.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$154.50M 10-Q · filed 2024-07-31 | -$992.90M derived: sum of 3 quarters · filed 2025-02-28 | -$1.06B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$206.60M 10-Q · filed 2024-04-29 | -$1.04B derived: sum of 2 quarters · filed 2025-02-28 | -$1.11B derived: sum of 3 quarters · filed 2025-02-28 | -$1.42B derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$838.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$908.30M derived: sum of 2 quarters · filed 2025-02-28 | -$1.22B derived: sum of 3 quarters · filed 2025-02-28 | -$1.58B 10-K · filed 2025-02-28 |
| 2022-09-30 | -$69.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$378.00M derived: sum of 2 quarters · filed 2023-10-27 | -$746.10M 10-Q · filed 2023-10-27 | -$808.10M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-06-30 | -$308.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$676.20M 10-Q · filed 2023-07-28 | -$738.20M derived: sum of 3 quarters · filed 2024-02-12 | -$699.20M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-03-31 | -$368.10M 10-Q · filed 2023-04-28 | -$430.10M derived: sum of 2 quarters · filed 2024-02-12 | -$391.10M derived: sum of 3 quarters · filed 2024-02-12 | -$450.10M derived: sum of 4 quarters · filed 2024-02-12 |
| 2021-12-31 | -$62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | -$23.00M derived: sum of 2 quarters · filed 2024-02-12 | -$82.00M derived: sum of 3 quarters · filed 2024-02-12 | -$356.30M 10-K · filed 2024-02-12 |
| 2021-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$20.00M derived: sum of 2 quarters · filed 2022-10-28 | -$294.30M 10-Q · filed 2022-10-28 | -$252.90M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | -$59.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | -$333.30M 10-Q · filed 2022-07-29 | -$291.90M derived: sum of 3 quarters · filed 2023-02-13 | -$257.90M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | -$274.30M 10-Q · filed 2022-04-28 | -$232.90M derived: sum of 2 quarters · filed 2023-02-13 | -$198.90M derived: sum of 3 quarters · filed 2023-02-13 | -$174.80M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $41.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $75.40M derived: sum of 2 quarters · filed 2023-02-13 | $99.50M derived: sum of 3 quarters · filed 2023-02-13 | -$486.90M 10-K · filed 2023-02-13 |
| 2020-09-30 | $34.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $58.10M derived: sum of 2 quarters · filed 2021-10-29 | -$528.30M 10-Q · filed 2021-10-29 | -$491.30M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-06-30 | $24.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$562.30M 10-Q · filed 2021-07-30 | -$525.30M derived: sum of 3 quarters · filed 2022-02-14 | -$490.90M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-03-31 | -$586.40M 10-Q · filed 2021-04-28 | -$549.40M derived: sum of 2 quarters · filed 2022-02-14 | -$515.00M derived: sum of 3 quarters · filed 2022-02-14 | -$746.40M derived: sum of 4 quarters · filed 2022-02-14 |
| 2019-12-31 | $37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $71.40M derived: sum of 2 quarters · filed 2022-02-14 | -$160.00M derived: sum of 3 quarters · filed 2022-02-14 | -$115.60M 10-K · filed 2022-02-14 |
| 2019-09-30 | $34.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | -$197.00M derived: sum of 2 quarters · filed 2020-10-26 | -$152.60M 10-Q · filed 2020-10-26 | -$997.30M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | -$231.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | -$187.00M 10-Q · filed 2020-07-27 | -$1.03B derived: sum of 3 quarters · filed 2021-02-12 | -$1.09B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $44.40M 10-Q · filed 2020-04-28 | -$800.30M derived: sum of 2 quarters · filed 2021-02-12 | -$857.00M derived: sum of 3 quarters · filed 2021-02-12 | -$1.10B derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | -$844.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$901.40M derived: sum of 2 quarters · filed 2021-02-12 | -$1.14B derived: sum of 3 quarters · filed 2021-02-12 | -$1.10B 10-K · filed 2021-02-12 |
| 2018-09-30 | -$56.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | -$297.40M derived: sum of 2 quarters · filed 2019-10-25 | -$256.50M 10-Q · filed 2019-10-25 | -$485.50M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | -$240.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | -$199.80M 10-Q · filed 2019-07-26 | -$428.80M derived: sum of 3 quarters · filed 2020-02-14 | -$408.50M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $40.90M 10-Q · filed 2019-04-26 | -$188.10M derived: sum of 2 quarters · filed 2020-02-14 | -$167.80M derived: sum of 3 quarters · filed 2020-02-14 | -$41.00M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | -$229.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$208.70M derived: sum of 2 quarters · filed 2020-02-14 | -$81.90M derived: sum of 3 quarters · filed 2020-02-14 | -$473.20M 10-K · filed 2020-02-14 |
| 2017-09-30 | $20.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $147.10M derived: sum of 2 quarters · filed 2018-10-26 | -$244.20M 10-Q · filed 2018-10-26 | |
| 2017-06-30 | $126.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$264.50M 10-Q · filed 2018-07-27 | ||
| 2017-03-31 | -$391.30M 10-Q · filed 2018-04-27 | |||
| 2016-12-31 | -$268.50M 10-K · filed 2019-02-15 | |||
| 2015-12-31 | -$158.60M 10-K · filed 2018-02-16 | |||
| 2011-06-30 | -$18.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $40.80M 10-Q · filed 2011-08-08 | $14.20M derived: sum of 3 quarters · filed 2011-08-08 | -$42.40M derived: sum of 4 quarters · filed 2011-08-08 |
| 2011-03-31 | $59.50M 10-Q · filed 2011-05-09 | $32.90M derived: sum of 2 quarters · filed 2011-05-09 | -$23.70M derived: sum of 3 quarters · filed 2011-05-09 | -$38.00M derived: sum of 4 quarters · filed 2011-08-08 |
| 2010-12-31 | -$26.60M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$83.20M derived: sum of 2 quarters · filed 2011-02-28 | -$97.50M derived: sum of 3 quarters · filed 2011-08-08 | -$103.90M 10-K · filed 2011-02-28 |
| 2010-09-30 | -$56.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$70.90M derived: sum of 2 quarters · filed 2011-08-08 | -$77.30M 10-Q · filed 2010-11-08 | -$73.40M derived: sum of 4 quarters · filed 2011-08-08 |
| 2010-06-30 | -$14.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$20.70M 10-Q · filed 2011-08-08 | -$16.80M derived: sum of 3 quarters · filed 2011-08-08 | -$43.10M derived: sum of 4 quarters · filed 2011-08-08 |
| 2010-03-31 | -$6.40M 10-Q · filed 2011-05-09 | -$2.50M derived: sum of 2 quarters · filed 2011-05-09 | -$28.80M derived: sum of 3 quarters · filed 2011-05-09 | |
| 2009-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$22.40M derived: sum of 2 quarters · filed 2011-02-28 | -$91.80M 10-K · filed 2011-02-28 | |
| 2009-09-30 | -$26.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$95.70M 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | -$69.40M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | -$134.10M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |